The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
ching ching!
Sorry, catching up. Guess most know our involvement with them,
Labskin is a 3-dimensional human skin equivalent model which has been designed for use in this space. It is used for basic and applied skin research, pre-clinical screening, microbial (bacterial) testing, and efficacy studies of personal care products. It is sold as both a consumable product to third parties, and a managed testing service conducting experiments from our facility in York. Sales in 2017 were to customers such as L'Occitane en Provence, Unilever and Galderma.
The Company continues its discussions with R&D departments of a number of cosmetic and pharmaceutical companies, independent testing companies and academic institutions, driven in part by the EU ban on animal testing in cosmetics
There's only one reason why James.
"Great to see marketing spend on your skins"
That's one of our top 20 cosmetic clients I believe.
Number 2 in the World: Unilever $21.3 billion
well 1750, GB just tweeted a Dove microbiome video.. coincidence?
That news alone would have been enough to raise some aim stocks 20%. Excellent news almost seems expected on a daily basis now maybe they've become immune to their meaning?
L'Occitane en Provence, the flagship brand of the Hong Kong Stock Exchange-listed company, achieved revenues of 1.247 billion euros, up 3.5% from the previous year. https://ww.fashionnetwork.com/news/L-occitane-international-reports-8-7-jump-in-annual-revenue,1094842.html
very good endorsement that, especially with new "top 20 global cosmetics super corps" dipping a toe in with us... be nice to hear the dove from above saying the same ;)
Congrats again to GB and the team.
Thats huge! Some serious recognition
The below tweet is step forward for the company as their hands have been tied with NDAs but now there is a major validation from a very large company! @LOccitane_FR http://t.co/J9ufCwhZJK?amp=1
Others will see this and want in too.
labskin
@Labskin
·
2h
@LOccitane_FR
just spoke at Skin Congress about how good our skin model, and how their lab team is getting fantastic data from it. Great to get this public validation!
“Building a functional understanding of the microbiome to transform drug-discovery and improve health outcomes.”
Over the last five years, the Annual European Microbiome Congress has developed into a trusted learning and networking platform for those who require insight into the latest microbiome research, clinical trials and multi-disciplinary collaborations, including:
Academics
Practising Clinicians
Pharmaceutical and Nutrition companies
Biotech Entrepreneurs and Investors
Government and Regulatory Bodies
Industry Leaders
The congress boasts an attendance of over 200 delegates each year, with a ratio of 50:50 of academics and industry leaders. More than five separate microbiome niches are explored with over 50 top leading speakers from academia and industry.
Labskin will present at the event as well as meeting with customers, industry leaders and leading academics in the microbiome field to deepen our collaboration.
For further information go here.
If you would like to arrange a meet up at the conference please fill in the form below. Thank you!